Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Geisinger’s Fresh Food Farmacy provides a “prescription” for healthy food to people with type 2 diabetes who are food insecure; plus, a Q&A with Geisinger
Using time-in-range to assess risk for complications, Omnipod Horizon Closed Loop, Bihormonal closed loop (insulin + Pramlintide), SGLT-2 oral drug for type 1, and more!
At the Lilly Diabetes Bloggers Summit, diaTribe got to hold a prototype of Lilly’s new, disk-like pump, which will integrate with Dexcom G6 CGM in a hybrid-closed loop...
The smart insulin pen’s Android app is expected to launch later this year in the US; a Europe launch is expected in 2019. Plus, learn about four other smart pens/caps in...
A restaurant mistake and four lessons I’m taking away from it…
Admelog will launch this year as the first approved biosimilar rapid-acting insulin. Will it be less expensive than Humalog?
How you can get a copy of Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me.
Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!
Zealand Pharma shared positive trial results for its dasiglucagon – 99% of participants recovered from hypo within 15 minutes of treatment
Our readers have spoken! See ten of the most popular diaTribe articles.
Foot and hand cream, moisturizing cream, and cleansing wash now available at Walgreens, Target, and
Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.
By Peter Rentzepis and Kelly Close Passing of Dr. Lois Jovanovic, the leading figure in pregnancy and diabetes, brings sorrow to many; friends and colleagues share...
Transitioning care from parent to child can be a stressful time for families with diabetes – six strategies on how to reduce the burden
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
Why it’s a big deal for the closed loop and pump fields, when it might be available, and how Tidepool is working with the FDA and companies to make it happen
A huge milestone that makes Forxiga the first pill for people with type 1 diabetes in Europe
Google’s health arm Verily/Alcon has announced that its project to develop a glucose-sensing contact lens has been put on hold
Read about Kelly’s better quality of life on Loop, as well as the difficulties that ultimately ended her Looping experience; part 2 of a series on a hybrid-closed-loop...
DIY Loop virtual study requires no in-person visits and seeks 300-1,000 Loop users, especially those new to Looping. Data will support eventual FDA submission of...